Karyopharm Therapeutics
KPTI | NASDAQ
$0.11
-$0.55 (-83.38%)
At close: Nov 2, 2026, 4:00 PM ET
Karyopharm Therapeutics Statistics
Key statistics explainedMarket Data
$2.54M
$153.32M
1.04
2.3M
28.94M
235.71%
73.18%
NASDAQ
US48576U2050
Price Performance
-86.3%
-94.4%
-98.8%
-98.5%
-98.2%
-99.2%
-99.9%
-64.8%
-89.1%
-61.6%
-40.8%
Valuation
-0.01
N/A
0.00
0.00
0.02
0.00
-0.01
-0.04
-0.03
-0.05
1.05
-0.87
-0.87
-2.35
-11881.8%
-2572.4%
-3030.7%
Financial Health
$144.53M
$215.89M
$65.11M
$111.32M
0.79
0.76
-0.65
-1.23
-3.30
-0.30
-1.67
-27.43
2
Margins & Profitability
95.9%
-56.2%
-119.9%
-153.3%
-44.6%
-52.5%
7.9%
-17.8%
Returns
-201.9%
77.6%
376.9%
359.4%
-201.9%
Historical Growth (CAGR)
0.1%
7.5%
97.9%
18.2%
-21.8%
16.4%
32.7%
5.3%
4.0%
Analyst Forecasts
Buy
4
34.4%
68.8%
Nov 2, 2026
-$0.95
-75.2%
$33.54M
-23.9%
Fair Value Estimates
N/A
N/A
N/A
N/A
$7.33
6563.6%
Cash Flow
$-65.35M
$-65.35M
$-76.99M
-$2.26
-$2.26
-44.6%
Income Statement
$146.62M
$140.58M
$-82.35M
$-175.85M
$-224.74M
-$13.07
$643.07K
$-985.7K
228
Add to Watchlist
Select watchlists to add or remove KPTI